The fight goes on: Clinical trial shows promising new treatment for rare blood cancer
Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white…
Browsing: Lymphoma
Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive…
A new therapeutic target turns the immune system against lymphoma
Non-Hodgkin lymphoma (NHL) is a group of cancers that originate in the lymph nodes and…
Lymphoma’s different route revealed
Creating new blood vessels, a process called angiogenesis, for tumours in lymph nodes is different…
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba, Japan, show that angioimmunoblastic T-cell lymphoma (AITL) is dependent…
DNA topological problems may cause lymphoma
Researchers from the Spanish National Cancer Research Centre (CNIO), Madrid, and the Andalusian Molecular Biology…
New front opened in fight against common cancer driver
Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are…
New study finds cellular immunotherapy treatment associated with improved quality of life
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy…
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukaemia and lymphoma
According to results from a Phase I/IIa trial at The University of Texas MD Anderson…
Drug profiling and gene scissors open new avenues in immunotherapy
Researchers have discovered ways to boost CAR T-cell therapy. According to a study published in…